Thromb Haemost 2010; 103(05): 875-876
DOI: 10.1160/TH10-03-0205
Theme Issue Editorial
Schattauer GmbH

Thrombosis and cardiovascular disease: Exciting perspectives in cardiovascular prevention and therapy

Karlheinz Peter
1   Baker Heart Research Institute, Centre for Thrombosis & Myocardial Infarction, Melbourne, Victoria, Australia
,
Gregory Y. H. Lip
2   Haemostasis, Thrombosis & Vascular Biology Unit, University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK
› Author Affiliations
Further Information

Publication History

Received: 31 March 2010

Accepted after major revision: 31 March 2010

Publication Date:
22 November 2017 (online)

 

 
  • References

  • 1 Schroecksnadel K, Grammer TB, Boehm BO. et al. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemost 2010; 103: 926-935.
  • 2 Di Minno MND, Tremoli E, Di Minno G. Homo-cysteine and arterial thrombosis: challenge and opportunity. Thromb Haemost 2010; 103: 942-961.
  • 3 Loeffler C, Straub A, Bassler N. et al. Evaluation of platelet activation in patients supported by the Jarvik 2000* high-rotational speed impeller ventricular assist device. J Thorac Cardiovasc Surg 2009; 137: 736-741.
  • 4 Heilmann C, Geisen U, Nakamura L. et al. Acquired von Willebrand syndrome in patients wiht ventricular assist devide or total artificial heart. Thromb Haemost 2010; 103: 962-967.
  • 5 Lankeit M, Konstantinides S. Thrombolysis for pulmonary embolism: Past, present and future. Thromb Haemost 2010; 103: 877-883.
  • 6 Burggraf D, Vosko MR, Schubert M. Different therapy options protecting microvasculature after experimental cerebral ischemia and reperfusion. Thromb Haemost 2010; 103: 891-900.
  • 7 Harmsze AM, Robijins K, von Werkum JW. et al. The use of amlodipine, but not of P-glycoprotein inhibiting calcium channel blockers in associated with clopidogrel poor-response. Thromb Haemost 2010; 103: 920-925.
  • 8 Van Walderveen MC, Berry LR, Atkinson HM. et al. Covalent antithrombin-heparin effect on thrombin-thrombomodulin and activated protein C reaction with factor V/Va. Thromb Haemost 2010; 103: 910-919.